Court finds invalidity defence raised after failed non-infringement claim to be abuse of process
The Federal Court of Appeal has deemed an invalidity defence raised by a generic drug manufacturer in a patent dispute an abuse of process, citing the company's prior unsuccessful non-infringement claim...To view the full article, register now.
Already a subscriber? Click here to view full article